Announcements Trials
Browse Landscape

Phase

Phase 2 31Phase 1 8Phase 3 6Phase 1/2 6Phase NA 3Phase EARLY_PHASE1 3Phase 2/3 3

Status

Recruiting 2Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Dermatologic 1

Conditions

Pancreatic Neoplasms 4Neoplasms, Basal Cell 1Localized Pancreatic Adenocarcinoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × folfirinox × Clear all
NCT06483555 2026-04-23

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
104 enrolled
DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

NCT03828799 2026-02-27

FOLFIRINOX-R

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed
13 enrolled 22 charts
Gastrointestinal

Colorectal Neoplasms

NCT06384560 2026-02-13

PREOPANC-5

Amsterdam UMC, location VUmc

Phase 1/2 Recruiting
66 enrolled
Gastrointestinal

Localized Pancreatic Adenocarcinoma

NCT05121038 2024-12-17

CENDIFOX

University of Kansas Medical Center

Phase 1/2 Active not recruiting
50 enrolled
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms

NCT04324307 2023-09-01

Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer

Changhai Hospital

Phase 1/2 Unknown
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01488552 2016-08-18

Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

Pancreatic Cancer Research Team

Phase 1/2 Completed
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡